Breast Cancer Res
-
Publication Venue For
- Polyfunctional anti-human epidermal growth factor receptor 3 (anti-HER3) antibodies induced by HER3 vaccines have multiple mechanisms of antitumor activity against therapy resistant and triple negative breast cancers.. 20:90. 2018
- Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer.. 20:22. 2018
- Frequency of breast cancer subtypes among African American women in the AMBER consortium.. 20:12. 2018
- Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study.. 19:131. 2017
- Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy.. 19:18. 2017
- Intratumoral heterogeneity as a source of discordance in breast cancer biomarker classification.. 18:68. 2016
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus.. 18:64. 2016
- Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth.. 17:528. 2015
- Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion.. 17:128. 2015
- Lobular breast cancer series: imaging.. 17:94. 2015
- Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance.. 17:91. 2015
- Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth.. 17:20. 2015
- An unexpected alliance between stress responses to drive oncogenesis.. 16:471. 2014
- DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.. 16:450. 2014
- A joint analysis of metabolomics and genetics of breast cancer.. 16:415. 2014
- A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype.. 16:407. 2014
- Refining the role of BRCA1 in combating oxidative stress.. 15:320. 2013
- An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models.. 15:R85. 2013
- Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.. 15:R73. 2013
- Therapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancer.. 15:R101. 2013
- Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes.. 14:R155. 2012
- S-nitrosylation of Ras in breast cancer.. 14:113. 2012
- Sex hormone changes during weight loss and maintenance in overweight and obese postmenopausal African-American and non-African-American women.. 14:R141. 2012
- Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.. 14:R130. 2012
- Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.. 14:R129. 2012
- Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.. 14:R89. 2012
- Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer.. 14:R62. 2012
- Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.. 13:R62. 2011
- Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management.. 13:205. 2011
- Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases.. 13:R125. 2011
- Akt is required for Stat5 activation and mammary differentiation.. 12:R72. 2010
- Akt is required for Stat5 activation and mammary differentiation.. 12:R72. 2010
- Optical breast cancer margin assessment: an observational study of the effects of tissue heterogeneity on optical contrast.. 12:R91. 2010
- An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.. 11:R55. 2009
- Plasma carotenoids, retinol, and tocopherols and postmenopausal breast cancer risk in the Multiethnic Cohort Study: a nested case-control study.. 11:R49. 2009
- Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer.. 10:R45. 2008
- Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation.. 9:R36. 2007
- Predicting a local recurrence after breast-conserving therapy by gene expression profiling.. 8:R62. 2006
- The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study.. 7:R871-R880. 2005
- Manganese superoxide dismutase Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites.. 6:R264-R274. 2004
- DNA damage response pathways in cancer causation and treatment 2005